April 14, 2020 Edition
COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.
When delivered to mice using microneedles, an experimental vaccine for COVID-19 caused antibody production against the disease within two weeks.
|
In experiments in cells and mice, blocking a cell receptor called LPR1 stopped both normal and harmful forms of tau, which are involved in dementias, from spreading between neurons.
|
Researchers found that a small cluster of mutations in the NLGN4X gene, which has been linked to autism spectrum disorder, may explain the sex differences tied to the gene.
|
Popular Stories
|
No hay comentarios:
Publicar un comentario